Comparison | Studies | RR (95%CI) | PA value | I2 | PH value | Model | |
---|---|---|---|---|---|---|---|
Overall | 7 | 1.34(1.20, 1.50) | < 0.001 | 0.0 | 0.544 | F | |
Subgroup | |||||||
Country | Asian | 7 | 1.34(1.20, 1.50) | < 0.001 | 0.0 | 0.544 | F |
Non-Asian | 0 | – | – | – | – | – | |
Sample size | < 200 | 3 | 1.30(1.05, 1.61) | 0.017 | 0.0 | 0.707 | F |
> 200 | 4 | 1.36(1.19, 1.55) | < 0.001 | 27.3 | 0.248 | F | |
Cut-off | < 600 | 4 | 1.18(0.97, 1.43) | 0.094 | 0.0 | 0.393 | F |
> 600 | 3 | 1.46(1.27, 1.67) | < 0.001 | 0.0 | 0.972 | F | |
Cancer type | Cervical cancer | 2 | 1.04(0.74, 1.48) | 0.807 | 0.0 | 0.338 | F |
Ovarian cancer | 2 | 1.47(1.23, 1.75) | < 0.001 | 0.0 | 0.881 | F | |
Breast cancer | 3 | 1.35(1.15, 1.59) | < 0.001 | 0.0 | 0.617 | F | |
TNBC | 1 | 1.43(1.13, 1.80) | 0.0003 | – | – | – | |
Other BC type | 2 | 1.29(1.03, 1.60) | 0.026 | 0.0 | 0.404 | F | |
Follow-up | < 48 m | 5 | 1.31(1.13, 1.52) | < 0.001 | 16.4 | 0.310 | F |
> 48 m | 2 | 1.41(1.19, 1.66) | < 0.001 | 0.0 | 0.822 | F |